Helix Health Initiative: Expected average contribution per individual client of $1,000 annually or $100 monthly. Helix Health Initiative clients are collectively paying Double Helix to develop, demonstrate and put through clinical trials, therapies that they wish to have available in the future.
During the typical 15 to 20 plus year period that it takes to obtain FDA or equivalent approvals for a new therapy, Helix Therapy access will be limited to participation in clinical trials.
Clients who contribute towards the development and testing of the therapy will be the first to benefit from any available early access. Cumulative contributions will qualify for priority of access to limited pay-for-treatment clinical trials at international medical clinics in jurisdictions where pay-for-treatment clinical trials are allowed.
This innovative approach provides a mechanism for clients to fund the development of desirable therapies.